Jean-Christophe PLANTIER

PU-PH – Rouen

Directeur de l’unité

 

jc.plantier@chu-rouen.fr
Accueil PRÉSENTATION DE L’ÉQUIPE Composition de l’équipe Jean-Christophe PLANTIER
Jean-Christophe Plantier
120 documents

Articles dans une revue81 documents

  • Ségolène Gracias, Ikrame El Yaalaoui, Benoît Visseaux, Charlotte Charpentier, Diane Descamps, et al.. In vitro phenotypic susceptibility of HIV-1 non-group M to CCR5 inhibitor (maraviroc): TROPI-CO study. Microbiology Spectrum, 2024, Online ahead of print. ⟨10.1128/spectrum.03895-23⟩. ⟨hal-04615634⟩
  • Simplice Dzamitika, Françoise Le Boulaire, Catherine Coignard, Claire Vincent, Jean-Christophe Plantier, et al.. Performance Evaluation of the Access anti-HBc Total Assay on the DxI 9000 Access Immunoassay Analyzer. Diagnostic Microbiology and Infectious Disease, 2024, pp.116303. ⟨10.1016/j.diagmicrobio.2024.116303⟩. ⟨hal-04560988⟩
  • Avelin Aghokeng, Nicole Ngo-Giang-Huong, Thu Huynh, Anoumou Dagnra, Thomas D’aquin Toni, et al.. Prevalence of pretreatment HIV resistance to integrase inhibitors in West African and Southeast Asian countries. Journal of Antimicrobial Chemotherapy, 2024, 79 (5), pp.1164-1168. ⟨10.1093/jac/dkae087⟩. ⟨hal-04533843⟩
  • Benoit Visseaux, Jérémie Gautier, Françoise Le Boulaire, Catherine Coignard, Claire Vincent, et al.. Performance evaluation of the Access HBsAg and Access HBsAg confirmatory assays on the DxI 9000 Access immunoassay analyzer. Practical Laboratory Medicine, 2024, pp.e00390. ⟨10.1016/j.plabm.2024.e00390⟩. ⟨hal-04510055⟩
  • Elodie Alessandri-Gradt, Camille Charbonnier, Jean-Christophe Plantier, Hélène Marini, Damien Costa, et al.. Knowledge, attitudes and practices of French university students towards COVID-19 prevention—are health students better?. PLoS ONE, 2023, 18 (11), pp.e0287716. ⟨10.1371/journal.pone.0287716⟩. ⟨hal-04275531⟩
  • Boris K Tchounga, Mélanie Bertine, Florence Damond, Valentine Marie Ferré, André Inwoley, et al.. Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa.. PLoS ONE, 2023, 18 (3), pp.e0283602. ⟨10.1371/journal.pone.0283602⟩. ⟨hal-04228561⟩
  • Laurent Mandelbrot, Roland Tubiana, Pierre Frange, Gilles Peytavin, Jérôme Le Chenadec, et al.. Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study. Journal of Antimicrobial Chemotherapy, 2023, 78 (7), pp.1711-1722. ⟨10.1093/jac/dkad161⟩. ⟨hal-04191629⟩
  • Vincent Guiraud, Jonathan Bocobza, Marion Desmonet, Florence Damond, Jean-Christophe Plantier, et al.. Are confirmatory assays reliable for HIV-1 / HIV-2 infection differentiation? A multicenter study. Journal of Clinical Microbiology, In press, ⟨10.1128/jcm.00619-23⟩. ⟨hal-04164703⟩
  • Alice Moisan, Brice Mastrovito, Fabienne de Oliveira, Mélanie Martel, Hugues Hedin, et al.. Evidence of transmission and circulation of Deltacron XD recombinant SARS-CoV-2 in Northwest France. Clinical Infectious Diseases, 2022, ⟨10.1093/cid/ciac360⟩. ⟨hal-03706342⟩
  • A. Maisa, G. Spaccaferri, L. Fournier, J. Schaeffer, J. Deniau, et al.. First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022. Infectious Diseases Now, 2022, 52 (3), pp.160-164. ⟨10.1016/j.idnow.2022.02.003⟩. ⟨hal-03678985⟩
  • A. Maisa, G. Spaccaferri, L. Fournier, J. Schaeffer, J. Deniau, et al.. First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022. Infectious Diseases Now, 2022, 52 (3), pp.160-164. ⟨10.1016/j.idnow.2022.02.003⟩. ⟨hal-04373016⟩
  • Charlène Martin, Guillemette Unal, Jean-Christophe Plantier, Elodie Alessandri-Gradt. Bictegravir-based antiretroviral therapy in HIV-1 group O patients: data from real-life bictegravir/emtricitabine/tenofovir alafenamide switches. Journal of Antimicrobial Chemotherapy, 2022, ⟨10.1093/jac/dkac143⟩. ⟨hal-03706317⟩
  • Brice Mastrovito, Chloé Naimi, Leslie Kouam, Xavier Naudot, Lucie Fournier, et al.. Investigation of outbreak cases infected with the SARS-CoV-2 B.1.640 variant in a fully vaccinated elderly population, Normandy, France, November to December 2021. Eurosurveillance, 2022, 27 (6), ⟨10.2807/1560-7917.ES.2022.27.6.2200078⟩. ⟨hal-03706394⟩
  • Gonché Danesh, Baptiste Elie, Yannis Michalakis, Mircea T Sofonea, Antonin Bal, et al.. Early phylodynamics analysis of the COVID-19 epidemic in France. Peer Community Journal, 2021, 1, pp.e45. ⟨10.24072/pcjournal.40⟩. ⟨hal-03001114v2⟩
  • Nadège Néant, Guillaume Lingas, Quentin Le Hingrat, Jade Ghosn, Ilka Engelmann, et al.. Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort. Proceedings of the National Academy of Sciences of the United States of America, 2021, 118 (8), pp.e2017962118. ⟨10.1073/pnas.2017962118⟩. ⟨hal-03364267⟩
  • Mélanie Bouvin-Pley, Marie Leoz, Emmanuelle Roch, Alain Moreau, Julie Migraine, et al.. Differential utilization of CD4+ by transmitted/founder and chronic envelope glycoproteins in a MSM HIV-1 subtype B transmission cluster. AIDS. Official journal of the international AIDS Society, 2020, 34 (15), pp.2187 - 2200. ⟨10.1097/qad.0000000000002690⟩. ⟨inserm-03451881⟩
  • Edouard Tuaillon, Dramane Kania, Amandine Pisoni, Karine Bolloré, Fabien Taieb, et al.. Dried Blood Spot Tests for the Diagnosis and Therapeutic Monitoring of HIV and Viral Hepatitis B and C. Frontiers in Microbiology, 2020, 11, ⟨10.3389/fmicb.2020.00373⟩. ⟨hal-02886691⟩
  • Benoit Visseaux, Lambert Assoumou, Nadia Mahjoub, Maxime Grude, Mary-Anne Trabaud, et al.. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?. Journal of Antimicrobial Chemotherapy, 2019, 75 (1), pp.183-193. ⟨10.1093/jac/dkz404⟩. ⟨hal-02359382⟩
  • Marc Wirden, Fabienne de Oliveira, Magali Bouvier-Alias, Sidonie Lambert-Niclot, Marie-Laure Chaix, et al.. New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017. Eurosurveillance, 2019, 24 (39), ⟨10.2807/1560-7917.ES.2019.24.39.1800658⟩. ⟨hal-02383043⟩
  • Mehdi Hage-Sleiman, Pauline Trémeaux, Marine Fillion, Faroudy Boufassa, Adeline Mélard, et al.. False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers. Clinical Infectious Diseases, 2019, ⟨10.1093/cid/ciz734⟩. ⟨hal-02382971⟩
  • A. Moisan, F. de Oliveira, C. Pronier, P. Cappy, A. Maillard, et al.. In vivo emergence of an HIV-1/MO recombinant revealed undiagnosed HIV-1/M+O co-infection. Clinical Microbiology and Infection, 2019, ⟨10.1016/j.cmi.2019.08.016⟩. ⟨hal-02344120⟩
  • Charles Kouanfack, Guillemette Unal, Laura Schaeffer, Anfumbom Kfutwah, Avelin Aghokeng, et al.. Comparative Immunovirological and Clinical Responses to Antiretroviral Therapy Between HIV-1 Group O and HIV-1 Group M Infected Patients. Clinical Infectious Diseases, 2019, ⟨10.1093/cid/ciz371⟩. ⟨hal-02383168⟩
  • Lambert Assoumou, Laurence Bocket, Coralie Pallier, Maxime Grude, Rachid Ait-Namane, et al.. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France. Journal of Antimicrobial Chemotherapy, 2019, 74 (5), pp.1417-1424. ⟨10.1093/jac/dkz011⟩. ⟨hal-02154058⟩
  • Adeline Baron, Albane Gicquel, Jean-Christophe Plantier, Marie Gueudin. Evaluation of four commercial extraction-quantification systems to monitor EBV or CMV viral load in whole blood. Journal of Clinical Virology, 2019, 113, pp.39 - 44. ⟨10.1016/j.jcv.2019.03.001⟩. ⟨hal-03486392⟩
  • Jilian Sacks, Youyi Fong, Mercedes Perez Gonzalez, Mauro Andreotti, Shrikala Baliga, et al.. Performance of Cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure. AIDS. Official journal of the international AIDS Society, 2019, 33 (12), pp.1881-1889. ⟨10.1097/QAD.0000000000002303⟩. ⟨hal-02383123⟩
  • Elodie Alessandri-Gradt, Guillemette Unal, Marie Leoz, Jean-Christophe Plantier. Virological response to integrase strand transfer inhibitor-based antiretroviral combinations in HIV-1 group O-infected patients. AIDS. Official journal of the international AIDS Society, 2019, 33 (8), pp.1327-1333. ⟨10.1097/QAD.0000000000002215⟩. ⟨hal-02383175⟩
  • V. Avettand-Fenoel, A. Mélard, Marie Gueudin, A. Maillard, J. Dina, et al.. Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains. Journal of Clinical Virology, 2019, 110, pp.36-41. ⟨10.1016/j.jcv.2018.12.002⟩. ⟨hal-02155359⟩
  • Thomas Mourez, Veronique Lemée, Valérie Delbos, Constance Delaugerre, Elodie Alessandri-Gradt, et al.. HIV rapid screening tests and self-tests: Be aware of differences in performance and cautious of vendors. EBioMedicine, 2018, 37, pp.382-391. ⟨10.1016/j.ebiom.2018.10.012⟩. ⟨hal-02372796⟩
  • Elodie Alessandri-Gradt, Charlotte Charpentier, Marie Leoz, Thomas Mourez, Diane Descamps, et al.. Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir. Journal of Antimicrobial Chemotherapy, 2018, 73 (10), pp.2716-2720. ⟨10.1093/jac/dky271⟩. ⟨hal-02383269⟩
  • L Lambert-Niclot, C Grude, L. Chaix, L Charpentier, C Reigadas, et al.. Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study). Journal of Antimicrobial Chemotherapy, 2018, 73 (8), pp.2147 - 2151. ⟨10.1093/jac/dky142⟩. ⟨hal-01899927⟩
  • Paul Alain Tagnouokam Ngoupo, Serge Alain Sadeuh-Mba, Fabienne de Oliveira, Elodie Téclaire Ngo-Malabo, Laure Ngono, et al.. Short Communication: Characterization of a New HIV-1 Group N Isolate Originating from a Cameroonian Patient. AIDS Research and Human Retroviruses, 2018, 34 (7), pp.621-625. ⟨10.1089/AID.2018.0015⟩. ⟨hal-02383284⟩
  • Francois Rouet, Janin Nouhin, Du-Ping Zheng, Benjamin Roche, Allison Black, et al.. Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014–2015. Clinical Infectious Diseases, 2018, 66 (11), pp.1733-1741. ⟨10.1093/cid/cix1071⟩. ⟨hal-02393988⟩
  • Guillemette Unal, Elodie Alessandri-Gradt, Marie Leoz, Juliette Pavie, Clément Lefèvre, et al.. Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals. Clinical Infectious Diseases, 2018, 66 (11), pp.1785-1793. ⟨10.1093/cid/cix1087⟩. ⟨hal-04265280⟩
  • Guillemette Unal, Elodie Alessandri-Gradt, Marie Leoz, Juliette Pavie, Clément Lefèvre, et al.. Human Immunodeficiency Virus Type 1 Group O Infection in France: Clinical Features and Immunovirological Response to Antiretrovirals. Clinical Infectious Diseases, 2018, 66 (11), pp.1785-1793. ⟨10.1093/cid/cix1087⟩. ⟨inserm-02129078⟩
  • Thomas Mourez, Amandine Decroos, Odile Goria, Hélène Montialoux, Fabienne de Oliveira, et al.. Misidentification of recombinant hepatitis C virus leading to treatment failure with direct acting antivirals. Journal of Medical Virology, 2018, 90 (5), pp.994-997. ⟨10.1002/jmv.25035⟩. ⟨hal-02059883⟩
  • Charlotte Charpentier, Isabelle Malet, Elisabeth André-Garnier, Alexandre Storto, Laurence Bocket, et al.. Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen. Journal of Antimicrobial Chemotherapy, 2018, 73 (4), pp.1039-1044. ⟨10.1093/jac/dkx511⟩. ⟨hal-01984177⟩
  • Elodie Alessandri-Gradt, Fabienne de Oliveira, Marie Leoz, Veronique Lemée, David L Robertson, et al.. HIV-1 group P infection: towards a dead-end infection?. AIDS. Official journal of the international AIDS Society, 2018, 32 (10), pp.1317-1322. ⟨10.1097/QAD.0000000000001791⟩. ⟨hal-02383299⟩
  • Truong Tam Nguyen, Veronique Lemée, Karine Bolloré, Hai Vinh Vu, Karine Lacombe, et al.. Confirmation of HCV viremia using HCV RNA and core antigen testing on dried blood spot in HIV infected peoples who inject drugs in Vietnam. BMC Infectious Diseases, 2018, 18, pp.622. ⟨10.1186/s12879-018-3529-3⟩. ⟨hal-01949795⟩
  • Fabienne de Oliveira, Pierre Cappy, Veronique Lemée, Alice Moisan, Charlotte Pronier, et al.. Detection of numerous HIV-1/MO recombinants in France. AIDS. Official journal of the international AIDS Society, 2018, 32 (10), pp.1289-1299. ⟨10.1097/QAD.0000000000001814⟩. ⟨hal-02344126⟩
  • Pierre Cappy, Alice Moisan, Fabienne de Oliveira, Jean-Christophe Plantier, Matteo Negroni. HIV-1 sequences in the epidemic suggest an alternative pathway for the generation of the Long Terminal Repeats. Scientific Reports, 2017, 7 (1), ⟨10.1038/s41598-017-14135-z⟩. ⟨hal-02171270⟩
  • Pierre Gantner, Adeline Mélard, Florence Damond, Constance Delaugerre, Julia Dina, et al.. Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies. Journal of Medical Virology, 2017, 89 (11), pp.2047--2050. ⟨10.1002/jmv.24874⟩. ⟨hal-01760708⟩
  • Julie Yamaguchi, Catherine Brennan, Elodie Alessandri-Gradt, Jean-Christophe Plantier, Gavin Cloherty, et al.. HIV-2 Surveillance with Next-Generation Sequencing Reveals Mutations in a Cytotoxic Lymphocyte-Restricted Epitope Involved in Long-Term Nonprogression. AIDS Research and Human Retroviruses, 2017, 33 (4), pp.347-352. ⟨10.1089/AID.2016.0229⟩. ⟨hal-02441262⟩
  • Claudia Filippone, Fabienne de Oliveira, Edouard Betsem, Laura Schaeffer, Arnaud Fontanet, et al.. Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates. Virology, 2017, 503, pp.76 - 82. ⟨10.1016/j.virol.2016.12.026⟩. ⟨pasteur-01672853⟩
  • Katharina Mack, Kathrin Starz, Daniel Sauter, Simon Langer, Frederic Bibollet-Ruche, et al.. Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain. Journal of Virology, 2017, 91 (6), ⟨10.1128/JVI.02177-16⟩. ⟨hal-02394301⟩
  • Mélanie Bertine, Marie Gueudin, Adeline Mélard, Florence Damond, Diane Descamps, et al.. New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification. Journal of Clinical Microbiology, 2017, 55 (9), pp.2850-2857. ⟨10.1128/JCM.00755-17⟩. ⟨hal-02394155⟩
  • Fabienne de Oliveira, Thomas Mourez, Aurelia Vessière, Paul-Alain Ngoupo, Elodie Alessandri-Gradt, et al.. Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon. Retrovirology, 2017, 14, pp.1. ⟨10.1186/s12977-016-0324-3⟩. ⟨hal-02394198⟩
  • Denis Tebit, Hamish Patel, Annette Ratcliff, Elodie Alessandri, Joseph Liu, et al.. HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs. AIDS Research and Human Retroviruses, 2016, 32 (7), pp.676-688. ⟨10.1089/aid.2015.0318⟩. ⟨hal-02442657⟩
  • J.A. Jordan, J.C. Plantier, K. Templeton, A.H.B. Wu. Multi-site clinical evaluation of the Xpert® HIV-1 viral load assay. Journal of Clinical Virology, 2016, 80, pp.27-32. ⟨10.1016/j.jcv.2016.04.014⟩. ⟨hal-02442569⟩
  • Sylvie Zida, Edouard Tuaillon, Makoura Barro, Arnaud Kwimatouo Lekpa Franchard, Thérèse Kagoné, et al.. Estimation of HIV-1 DNA Level Interfering with Reliability of HIV-1 RNA Quantification Performed on Dried Blood Spots Collected from Successfully Treated Patients. Journal of Clinical Microbiology, 2016, 54 (6), pp.1641 - 1643. ⟨10.1128/JCM.03372-15⟩. ⟨hal-01872543⟩
  • Pierre Cappy, Fabienne de Oliveira, Marie Gueudin, Elodie Alessandri-Gradt, Jean-Christophe Plantier. A Multiplex PCR Approach for Detecting Dual Infections and Recombinants Involving Major HIV Variants. Journal of Clinical Microbiology, 2016, 54 (5), pp.1282-1288. ⟨10.1128/JCM.03222-15⟩. ⟨hal-02442627⟩
  • Michael Berg, Julie Yamaguchi, Elodie Alessandri-Gradt, Robert Tell, Jean-Christophe Plantier, et al.. A Pan-HIV Strategy for Complete Genome Sequencing. Journal of Clinical Microbiology, 2016, 54 (4), pp.868-882. ⟨10.1128/JCM.02479-15⟩. ⟨hal-02558523⟩
  • Agnès Gautheret-Dejean, Jonathan Bocobza, Sylvie Brunet, Florence Damond, Jean-Christophe Plantier, et al.. Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections. Journal of Medical Virology, 2016, 88 (3), pp.369-370. ⟨10.1002/jmv.24390⟩. ⟨hal-02558541⟩
  • Marion Morgand, Mélanie Bouvin-Pley, Jean-Christophe Plantier, Moreau Alain, Elodie Alessandri, et al.. V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1. Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2016, 71 (3), pp.237-245. ⟨10.1097/QAI.0000000000000854⟩. ⟨hal-01314296⟩
  • S. Ouédraogo Yugbaré, R. Ouédraogo, A. Nenebi, B. Traoré, L. Congo, et al.. Infections à virus respiratoire syncytial (VRS) au CHU pédiatrique Charles de Gaulle de Ouagadougou, Burkina Faso. Bulletin de la Société de pathologie exotique , 2016, 109 (1), pp.20-25. ⟨10.1007/s13149-016-0473-6⟩. ⟨hal-02367387⟩
  • Guillemette Unal, Thomas Mourez, Marie Leoz, Elodie Alessandri-Gradt, Helene Le Guillou-Guillemette, et al.. First report of transmission of a highly resistant strain of HIV-1 group O. AIDS. Official journal of the international AIDS Society, 2016, 30 (16), pp.2565-2568. ⟨10.1097/QAD.0000000000001253⟩. ⟨hal-02442557⟩
  • Marie Gueudin, Adeline Baron, Elodie Alessandri-Gradt, Veronique Lemée, Thomas Mourez, et al.. Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 Variants. Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2016, 72 (5), pp.521-526. ⟨10.1097/QAI.0000000000001003⟩. ⟨hal-02442601⟩
  • Agnès Gautheret-Dejean, Jonathan Bocobza, Sylvie Brunet, Florence Damond, Jean-Christophe Plantier, et al.. Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections. Journal of Medical Virology, 2015, 87 (12), pp.2061-2066. ⟨10.1002/jmv.24282⟩. ⟨hal-02563908⟩
  • Thomas Mourez, Constance Delaugerre, Muriel Vray, Veronique Lemée, Francois Simon, et al.. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0–HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants. Journal of Clinical Virology, 2015, 71, pp.76-81. ⟨10.1016/j.jcv.2015.08.007⟩. ⟨hal-02558554⟩
  • Pierre Frange, Pierre Assoumou, Diane Descamps, Antoine Chéret, Cécile Goujard, et al.. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies. Journal of Antimicrobial Chemotherapy, 2015, 70 (7), pp.2084-2089. ⟨10.1093/jac/dkv049⟩. ⟨hal-01983697⟩
  • Didier K. Ekouevi, Véronique Avettand-Fenoël, Boris Tchounga, Patrick A. Coffie, Adrien Sawadogo, et al.. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration. PLoS ONE, 2015, 10 (6), pp.e0129886. ⟨10.1371/journal.pone.0129886⟩. ⟨hal-02563887⟩
  • Sylvie Larrat, Sophie Vallet, Sandra David-Tchouda, Alban Caporossi, Jennifer Margier, et al.. Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin. Journal of Clinical Microbiology, 2015, 53 (7), pp.2195-2202. ⟨10.1128/JCM.03633-14⟩. ⟨hal-02014295⟩
  • Daniel Sauter, Dominik Hotter, Benoît Van driessche, Christina m. Stürzel, Silvia f. Kluge, et al.. Differential Regulation of NF-κB-Mediated Proviral and Antiviral Host Gene Expression by Primate Lentiviral Nef and Vpu Proteins. Cell Reports, 2015, 10 (4), pp.586-599. ⟨10.1016/j.celrep.2014.12.047⟩. ⟨hal-02569738⟩
  • Elodie Alessandri-Gradt, Marjolaine Morgand, Constance Delaugerre, Gilles Peytavin, Pierre Sellier, et al.. HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M. AIDS. Official journal of the international AIDS Society, 2015, 29 (10), pp.1271-1273. ⟨10.1097/QAD.0000000000000703⟩. ⟨hal-02564019⟩
  • Paul Alain Ngoupo, Serge Alain Sadeuh-Mba, Fabienne de Oliveira, Valérie Ngono, Laure Ngono, et al.. First evidence of transmission of an HIV-1 M/O intergroup recombinant virus. AIDS. Official journal of the international AIDS Society, 2015, 30 (1), pp.1-8. ⟨10.1097/QAD.0000000000000880⟩. ⟨hal-02442685⟩
  • Marie Leoz, Felix Feyertag, Anfumbom Kfutwah, Philippe Mauclère, Guillaume Lachenal, et al.. The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon. PLoS Pathogens, 2015, 11 (8), pp.e1005029. ⟨10.1371/journal.ppat.1005029⟩. ⟨hal-02558574⟩
  • Agnès Depatureaux, Thibault Mesplède, Peter Quashie, Maureen Oliveira, Daniela Moisi, et al.. HIV-1 Group O Resistance Against Integrase Inhibitors. Journal of Acquired Immune Deficiency Syndromes - JAIDS, 2015, 70 (1), pp.9-15. ⟨10.1097/QAI.0000000000000698⟩. ⟨hal-02569698⟩
  • Veronique Lemée, Marie Leoz, Manuel Etienne, Fabienne de Oliveira, Jean-Christophe Plantier. Performance of the Liaison XL Murex HIV Ab/Ag Test on Clinical Samples Representing Current Epidemic HIV Variants: TABLE 1. Journal of Clinical Microbiology, 2014, 52 (9), pp.3277-3279. ⟨10.1128/JCM.01089-14⟩. ⟨hal-02571094⟩
  • Jérémie Leporrier, Manuel Etienne, Claire Chapuzet, Gilles Peytavin, Stephane Bord, et al.. Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy. Journal of Clinical Virology, 2014, 60 (4), pp.428-430. ⟨10.1016/j.jcv.2014.05.004⟩. ⟨hal-02571128⟩
  • Diane Descamps, Lambert Assoumou, Marie-Laure Chaix, Antoine Chaillon, Sophie Pakianather, et al.. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011. Journal of Antimicrobial Chemotherapy, 2013, 68 (11), pp.2626-2631. ⟨10.1093/jac/dkt238⟩. ⟨hal-02291004⟩
  • Anne-Geneviève Marcelin, Constance Delaugerre, Céline Beaudoux, Diane Descamps, Laurence Morand-Joubert, et al.. A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.. International Journal of Antimicrobial Agents, 2013, 42 (1), pp.42-7. ⟨10.1016/j.ijantimicag.2013.02.016⟩. ⟨hal-00875083⟩
  • Lambert Assoumou, Diane Descamps, Sabine Yerly, Georges dos Santos, Anne-Geneviève Marcelin, et al.. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study. Journal of Antimicrobial Chemotherapy, 2013, 68 (6), pp.1400-5. ⟨10.1093/jac/dkt033⟩. ⟨hal-00875092⟩
  • Lambert Assoumou, Diane Descamps, Sabine Yerly, Georges dos Santos, Anne-Geneviève Marcelin, et al.. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.. Journal of Antimicrobial Chemotherapy, 2013, 68, pp.1400-5. ⟨hal-01101100⟩
  • Sophie Vallet, Sylvie Larrat, Syria Laperche, Hélène Le Guillou-Guillemette, Florence Legrand-Abravanel, et al.. Multicenter quality control of hepatitis C virus protease inhibitor resistance genotyping.. Journal of Clinical Microbiology, 2013, 51 (5), pp.1428-33. ⟨10.1128/JCM.03032-12⟩. ⟨hal-00935958⟩
  • S Reigadas, a G Marcelin, A Houssaïni, S Yerly, D Descamps, et al.. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.. Journal of Antimicrobial Chemotherapy, 2013, 68, pp.969-72. ⟨hal-01101120⟩
  • Julia Dina, Stephanie Raymond, Anne Maillard, Hélène Le Guillou-Guillemette, Audrey Rodalec, et al.. Algorithm-based prediction of HIV-1 subtype D coreceptor use. Journal of Clinical Microbiology, 2013, 51 (7), pp.3087-3089. ⟨10.1128/JCM.00798-13⟩. ⟨hal-03269741⟩
  • Martine Braibant, Eun-Yeung Gong, Jean-Christophe Plantier, François Simon, Francis Barin. Cross-group neutralization of HIV-1 and evidence for conservation of the PG9/PG16 epitopes within divergent groups of HIV-1. Retrovirology, 2012, 9 (Suppl 2), pp.P53. ⟨inserm-00731773⟩
  • Cathia Soulié, Constance Delaugerre, Laurence Morand-Joubert, Charlotte Charpentier, Virginie Ferre, et al.. Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice. Journal of Antimicrobial Chemotherapy, 2012, 67 (10), pp.2487 - 2493. ⟨10.1093/jac/dks226⟩. ⟨hal-03268578⟩
  • Cécile Henquell, Julien Guglielmini, Jannick Verbeeck, Antoine Mahul, Vincent Thibault, et al.. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study. Infection, Genetics and Evolution, 2011, 11 (2), pp.496-503. ⟨10.1016/j.meegid.2010.12.015⟩. ⟨hal-02014356⟩
  • Neel Cecile, Etienne Lucie, Li Yingying, Takehisa Jun, Rudicell Rebecca S., et al.. Molecular Epidemiology of Simian Immunodeficiency Virus Infection in Wild-Living Gorillas. Journal of Virology, 2009, 84, pp.1464 - 1476. ⟨10.1128/jvi.02129-09⟩. ⟨hal-03058000⟩
  • Armel Mintsa-Ndong, Melanie Caron, Jean-Christophe Plantier, Maria Makuwa, Simon Le Hello, et al.. High HIV Type 1 Prevalence and Wide Genetic Diversity with Dominance of Recombinant Strains But Low Level of Antiretroviral Drug-Resistance Mutations in Untreated Patients in Northeast Gabon, Central Africa. AIDS Research and Human Retroviruses, 2009, 25 (4), pp.411-418. ⟨10.1089/aid.2008.0223⟩. ⟨hal-03744731⟩
  • S. Laperche, F. Lunel, Jacques Izopet, Sophie Alain, P. Deny, et al.. Comparison of hepatitis C virus NS5b and 5' noncoding gene sequencing methods in a multicenter study. Journal of Clinical Microbiology, 2005, 43 (2), pp.733-739. ⟨10.1128/JCM.43.2.733-739.2005⟩. ⟨hal-00405619⟩

Communications dans un congrès6 documents

  • Elodie Alessandri-Gradt, Samuel Constant, Jean-Christophe Plantier, Georgios Stroulios, Stroulios Simmini, et al.. Génération d’organoïdes respiratoires avec exposition apicale externe. Journées normandes de recherche biomédicale, Jun 2023, Caen, France. ⟨hal-04276950⟩
  • Alice Michel, Jean-Christophe Plantier, Chervin Hassel. "Microbiosthme" : Upper and lower airway microbiomes analysis in infants with severe asthma. Journées de l'Ecole Doctorale Normande de Biologie Intégrative Santé et Environnement - 25ème édition, Ecole Doctorale normande de Biologie Intégrative, Santé, Environnement, Apr 2023, Rouen, France. ⟨hal-04123546⟩
  • Alice Michel, Chervin Hassel, Jean-Christophe Plantier. Upper and lower respiratory tract microbiomes analysis in infants with severe asthma. Congrès de la FHU RESPIRE, Fédération Hospitalo-Universitaire RESPIRE, Nov 2022, Forges-les-Eaux, France. ⟨hal-04123385⟩
  • Alice Moisan, Fabienne de Oliveira, Pierre Cappy, Paul-Alain Ngoupo, Aurelia Vessière, et al.. Évolution des VIH-1 groupes M et O : analyse génétique comparée de 20 formes recombinantes VIH-1 inter-groupes. Journées Francophones de Virologie, Mar 2019, Paris, France. ⟨hal-02345601⟩
  • Alice Moisan, Fabienne de Oliveira, Charlotte Pronier, Jean-Marc Chapplain, Pauline Tremeaux, et al.. Mise en évidence d'une co-infection VIH-1/M+O par l'émergence in vivo d'un recombinant VIH-1/MO. Journées Francophones de Virologie, Mar 2019, Lyon, France. ⟨hal-02345553⟩
  • M Leoz, A Depatureaux, D. Descamps, G. Collin, P Roques, et al.. Diversité génétique et antigénique des VIH-1 du groupe O. Journée de l'Institut Fédératif de Recherche Multidisciplinaire sur les Peptides, Jun 2007, Le Havre, France. ⟨hal-02265121⟩

Poster de conférence32 documents

  • Alice Michel, Marie Leoz, Nicolas Nesi, Meriadeg Le Gouil, Hortense Petat, et al.. RNA extraction optimization for both microbiome and virome analysis. Journée Normande de Recherche Biomédicale, Jun 2024, Rouen, France. ⟨hal-04617878⟩
  • Flora Archambault, Fabienne Tombette, Magalie Benard, Ludovic Galas, Caroline Tapparel, et al.. Respiratory organoids models from bronchial cells of asthmatic patients : Fabrication and study of viral infection permissivity. Journées normandes de recherche biomédicale (JNRB), Jun 2024, Rouen, France. . ⟨hal-04615618⟩
  • Manon Vautrin, Fabienne de Oliveira, Vinca Icard, Marie Leoz, Mary-Anne Trabaud, et al.. Mise en évidence de la transmission mère-enfant d'un VIH-1 recombinant intergroupes MO. JNRB, Jun 2023, Caen, France. ⟨hal-04185190⟩
  • Alice Michel, Chervin Hassel, Hortense Petat, Marie Leoz, Meriadeg Le Gouil, et al.. Upper and lower respiratory tract microbiomes analysis in infants with severe asthma. Journée Normande de Recherche Biomédicale, Jun 2023, Caen, France. ⟨hal-04123344⟩
  • Elodie Alessandri-Gradt, Samuel Constant, Jean-Christophe Plantier, Georgios Stroulios, Salvatore Simmini, et al.. Génération d'organoïdes respiratoires à exposition extérieure apicale à partir de cellules de pools de donneurs. Journées francophones de virologie, Apr 2023, Paris, France. ⟨hal-04276932⟩
  • A Michel, C Hassel, H Petat, M Leoz, Meriadeg Le Gouilh, et al.. Projet Microbiosthme : Dynamique des microbiomes respiratoires des voies supérieures et inférieures, associée à l'asthme sévère du nourrisson. Congrès de la FHU RESPIRE, Nov 2022, Forges-les-eaux, France. ⟨hal-04117856⟩
  • Alice Moisan, Brice Mastrovito, Fabienne de Oliveira, Mélanie Martel, Hugues Hedin, et al.. Transmission et circulation d'un recombinant SARS-CoV-2 Deltacron XD en Normandie. Journée Normande de Recherche Biomédicale (JNRB 2022), Jun 2022, Rouen, France. ⟨hal-03706243⟩
  • Adeline Baron, Audrey Mirand, Astrid Vabret, Jean Christophe Plantier, Marie Gueudin. Performances des trousses Panther/Fusion virus respiratoires (Hologic) chez les enfants de moins de 3 ans. RICAI, Dec 2018, Paris, France. ⟨hal-02270997⟩
  • Alice Moisan, Juliette Caron, Fabienne de Oliveira, Jean-Christophe Plantier. Analyse des régions LTR du génome d'un VIH-1 recombinant inter-groupes M et O : étude de l'émergence des points de cassure et caractérisation des différentes populations. 3ème Journée Normande de Recherche Biomédicale, Sep 2018, Rouen, France. . ⟨hal-02268783⟩
  • Albane Gicquel, Veronique Lemée, Marie Gueudin, Elodie Alessandri-Gradt, Jean-Christophe Plantier, et al.. Mise au point d'une méthode de quantification de l'ARN plasmatique spécifique des VIH-1 de groupe M. 3 ème Journée Normande de Recherche Biomédicale, Sep 2018, Rouen, France. . ⟨hal-02268770⟩
  • Marion Giry, Benoit Misset, Déborah Boyer, Adeline Baron, Ludovic Lemée, et al.. Presence of respiratory viruses in ICU patients with community acquired-pneumonia (CAP): a one-year restrospective single center study. ESCV, Sep 2018, Athènes, Greece. ⟨hal-02115833⟩
  • Juliette Caron, Alice Moisan, Fabienne de Oliveira, Jean-Christophe Plantier. Analyse et caractérisation des régions LTRs du génome d'un VIH-1 recombinant inter-groupes M et O. Journée Normande de Recherche Biomédicale, Nov 2017, Caen, France. ⟨hal-02266193⟩
  • Thomas Mourez, Veronique Lemée, Valérie Delbos, Constance Delaugerre, Manuel Etienne, et al.. Performance of 9 rapid diagnostic HIV tests on a wide panel of whole blood samples. IAS, Jul 2017, Paris, France. ⟨hal-02115971⟩
  • Alice Moisan, Fabienne de Oliveira, Pierre Cappy, Paul-Alain Ngoupo, Richard Njouom, et al.. Evolution of HIV-1 groups M and O: genetic comparative analysis of 23 HIV-1/MO inter-group recombinant forms. IAS, Jul 2017, Paris, France. ⟨hal-02115882⟩
  • A Moisan, F de Oliveira, P Cappy, P A Ngoupo, A Vessiere, et al.. Analyse génétique comparée de 19 formes recombinantes VIH-1 inter-groupes M et O et impact évolutif. Journée Normande de Recherche Biomédicale, Sep 2016, Rouen, France. ⟨hal-02265845⟩
  • Marie Leoz, Myriam Vezain, Elodie Alessandri-Gradt, Sophie Coutant, Guillemette Unal, et al.. Next Generation Sequencing Analysis of HIV-1 Group O Reverse Transcriptase Residue 181C Prevalence and Evolution over Time, With or Without Antiretroviral Selection Pressure. 23rd HIV Dynamics and Evolution, Apr 2016, Woods Hole, United States. ⟨hal-02264817⟩
  • Marie Leoz, Charlotte Charpentier, Constance Delaugerre, Marc Wirden, Veronique Lemée, et al.. Emergence of a New Circulating B/CRF02/G Recombinant Form Spreading in France. CROI, Mar 2016, Atlanta, United States. ⟨hal-02264832⟩
  • C. Kouanfack, M Vray, A Kfutwah, A Aghokeng, R Mougnutou, et al.. ANRS 12168 - Dynam-O study, comparing the immuno-virological and clinical responses to HAART between HIV-1 group O and group M-infected patients : results at 96 weeks. CROI ( Conference on Retroviruses and Opportunistic Infections), Feb 2016, Boston, United States. ⟨hal-02265828⟩
  • Paul-Alain Ngoupo, Serge Alain Sadeuh Mba, Fabienne de Oliveira, V Ngono, L Ngono, et al.. Evidence of Intra-Familial Transmission of an HIV-1 M/O Intergroup Recombinant Virus. IRIB, Jun 2015, Rouen, France. ⟨hal-02130009⟩
  • Anne Tourneroche, Elodie Alessandri-Gradt, Gilles Collin, Marie Leoz, Charlotte Charpentier, et al.. HIV-1 group O phenotypic susceptibility to integrase inhibitors. IRIB, Jun 2015, Rouen, France. ⟨hal-02116028⟩
  • Marie Leoz, Felix Feyertag, Anfumbom K. W. Kfutwah, Philippe Mauclère, Guillaume Lachenal, et al.. The Two Phases of HIV-1 Group O Diversification. IRIB, Jun 2015, Rouen, France. ⟨hal-02116005⟩
  • Pierre Cappy, Fabienne de Oliveira, Veronique Lemée, Jean-Louis Gaillard, Laurence Bocquet, et al.. HIV-1/M+O INTERGROUP DUAL INFECTIONS AND ASSOCIATED HIV-MO RECOMBINANTS IN FRANCE FROM 2004 TO 2014. IRIB, Jun 2015, Rouen, France. ⟨hal-02116062⟩
  • Pierre Cappy, Fabienne de Oliveira, Veronique Lemée, Jean-Louis Gaillard, Laurence Bocquet, et al.. DUAL HIV-1/M+O INFECTIONS AND HIV-1/MO RECOMBINANTS IN FRANCE FROM 2004 TO 2014. CROI, Feb 2015, Seattle, United States. ⟨hal-02115306⟩
  • V Lemée, N Nicolay, A M Roque, O Goria, V. Brunel, et al.. Epidémie d'hépatite A aiguë parmi des hommes ayant des rapports sexuels avec des hommes (HSH) Caractéristiques cliniques et épidémiologiques des cas diagnostiqués au CHU de Rouen. Journée Normande de Recherche Biomédicale, Nov 2014, Caen, France. ⟨hal-02266158⟩
  • Marie Leoz, Felix Feyertag, Jude Kfutwah, Philippe Mauclère, Florence Damond, et al.. Diversité et Évolution Génétique des VIH-1 de Groupe O. Journées Francophone de Virologie, Mar 2014, Paris, France. ⟨hal-02265062⟩
  • Marie Leoz, Florence Damond, Jude Kfutwah, Jean-Christophe Plantier, French Res-O Network. New Insights into HIV-1 Group O Diversity. CROI, Mar 2013, Atlanta, United States. ⟨hal-02264835⟩
  • M Leoz, M L Chaix, C. Delaugerre, C Rivoisy, L Meyer, et al.. Circulation of Multiple Patterns of Unique Recombinant Forms B/CRF02_AG in France. HIV Dynamics and Evolution, 2011, Galway, Ireland. ⟨hal-02272128⟩
  • M Leoz, F de Oliveira, A Kfutwah, A Vessiere, A Depatureaux, et al.. The presence of the Y181C mutation in HIV-1 group O strains is clade dependant. 16th International Bioinformatics Workshop on virus evolution and molecular epidemiology, Aug 2010, Baltimore, MD, United States. ⟨hal-02272178⟩
  • M Leoz, Alexandre Louvel, F. Barin, C Semaille, J C Plantier. Diversité génétique du HIV-1 en France : mise en évidence de formes mosaïques et de clusters de transmission. Journée de l'Institut Fédératif de Recherche Multidisciplinaure sur les Peptides, Jun 2010, Rouen, France. ⟨hal-02264869⟩
  • A Depatureaux, M Leoz, G. Le Moal, J P Pathe, J. Pavie, et al.. Utilisation du Raltegravir chez des patients infectés par HIV-1 group O. Journées Nationales d'Infectiologie, Jun 2009, Lyon, France. ⟨hal-02265066⟩
  • M Leoz, A Vessiere, V Brodard, C. Strady, A Depatureaux, et al.. First Evidence of a HIV-1 M/O Recombinant Form Circulating Outside Cameroon. CROI, Feb 2009, Montreal, Canada. ⟨hal-02264822⟩
  • M Leoz, A Depatureaux, A Vessiere, B Roquebert, F Damond, et al.. POLYMORPHISME DES VIH-O ET INHIBITEURS DE L'INTEGRASE. Journée de l'Institut Fédératif de Recherche Multidisciplinaire sur les Peptides, Jun 2008, Evreux, France. ⟨hal-02264866⟩

Article de blog scientifique1 document

  • Alice Moisan, Elodie Alessandri-Gradt, Fabienne de Oliveira, Jean-Christophe Plantier. Le séquençage des variants du Covid expliqué par ses spécialistes. 2022. ⟨hal-04039919⟩

Documents récupérés de l'archive ouverte HAL logo